Putting Our Heads Together
Posted in Brain Tumor Action Week, Events, Hats, News on May 8th, 2009
The Ohio State University Comprehensive Cancer Center th James Cancer Hospital and Solove Research Institute will host the second annual Brain Tumor Awareness and Survivor Day Celebration on Saturday (5/9) from 10:30 a.m. to 2:30 p.m. at The Fawcett Center, 2400 Olentangy River Road.
Posted in Brain Tumor Action Week, Early Detection, News on May 7th, 2009
Bobby Murcer Mobile MRI Unit in Washington, D.C. for Brain Tumor Awareness Month Provides Free Brain Scans to Members of Congress, Staff and Government Agency Officials.
The Burzynski Research Institute (BRI) announced today positive safety and efficacy results in its Phase II clinical trial of Antineoplaston A10 and Antineoplaston AS2-1 therapy (ANP therapy) in children with optic pathway glioma (OPG). The results were presented to the FDA in the Request for End of Phase II Meeting Briefing Package (ANP in OPG), to be discussed at a meeting with the FDA on May 7, 2009. The FDA responded to the questions in the Briefing Package and issued additional comments before the meeting. The answers and comments were clear, and the meeting was cancelled since further discussion was not required. Based on preliminary responses and additional comments from the FDA, a protocol for a Phase III randomized trial with ANP in OPG will be prepared and submitted for FDA Special Protocol Assessment (SPA) to secure agreement on the design of a Phase III trial to serve as an efficacy claim in a New Drug Application (NDA).
Posted in News on May 6th, 2009
Genentech, Inc. announced today that the U.S. Food and Drug Administration (FDA) granted accelerated approval of Avastin® (bevacizumab) for people with glioblastoma with progressive disease following prior therapy.
Posted in Brain Tumor Action Week, Early Detection, Events, News on May 4th, 2009
The Brain Tumor Foundation has launched an unprecedented campaign: Road to Early Detection, the first-ever national campaign promoting early detection of brain tumors through the use of a Mobile MRI Unit.
Posted in Brain Tumor Action Week, Events, News on May 4th, 2009
The annual Brain Tumor Vigil was held in Washington, DC on Sunday May 3, after the Race for Hope.
Posted in Brain Tumor Action Week, Events, News on May 3rd, 2009
David Cook announces his brother’s death from a brain tumor at the Race for Hope in Washington, DC.
Posted in Uncategorized on Apr 28th, 2009
Source: CancerConsultants.com
Researchers from the Children’s Hospital Los Angeles have reported that high-dose thiotepa-based autologous transplant regimens are effective in children with recurrent medulloblastoma (MB) and supratentorial primitive neuroectodermal tumors (PNET). The details of this study appeared in an early online publication in Cancer on April 28, 2009.[1]
Medulloblastoma is a relatively rare brain tumor in children [...]
Posted in News on Apr 22nd, 2009
After their 5-year-old son Adam died from an inoperable brain tumor in September, Doug and Sara Beiswanger wondered how their family would survive the pain.
U-M researchers develop ‘parametric response map’ to analyze changes in a tumor’s blood flow, volume.
